Integer Holdings (ITGR) Net Income towards Common Stockholders (2010 - 2025)

Integer Holdings' (ITGR) quarterly Net Income towards Common Stockholders came in at -$22000.0 in Q1 2025, up 73.49% year-on-year from -$12680.6 in Q1 2024, and up 91.85% quarter-over-quarter from -$270000.0 in Q4 2024.

Integer Holdings (ITGR) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends

Integer Holdings has disclosed Net Income towards Common Stockholders across 15 years of filings, most recently posting -$22000.0 for Q1 2025.

  • Net Income towards Common Stockholders for Q1 2025 came in at -$22000.0, up 73.49% year-over-year; the trailing twelve-month figure through Dec 2025 was -$22000.0 (up 98.1% YoY), and the FY2025 annual result was -$22000.0, up 98.1% from the prior year.
  • Net Income towards Common Stockholders came in at -$22000.0 for Q1 2025 at Integer Holdings, up from -$270000.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $29.4 million in Q3 2021 to a low of -$917000.0 in Q3 2023.
  • The 5-year median for Net Income towards Common Stockholders is $11.5 million (2022), against an average of $11.0 million.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 105.71% in 2023 and surged 73.49% in 2025, its largest moves.
  • Integer Holdings' Net Income towards Common Stockholders stood at $20.0 million in 2021, then plunged by 42.74% to $11.5 million in 2022, then tumbled by 103.98% to -$456000.0 in 2023, then surged by 40.79% to -$270000.0 in 2024, then surged by 91.85% to -$22000.0 in 2025.
  • The last three Net Income towards Common Stockholders figures came in at -$22000.0 (Q1 2025), -$270000.0 (Q4 2024), and -$843000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Integer Holdings 3.12 Bn 3.11 Bn 109.60 Mn -

Historic Data

Download Data
DateValue
Mar 28, 2025 -22,000.00
Dec 31, 2024 -270,000.00
Sep 27, 2024 -843,000.00
Jun 28, 2024 39,000.00
Mar 29, 2024 -83,000.00
Dec 31, 2023 -456,000.00
Sep 29, 2023 -917,000.00
Jun 30, 2023 23.98 Mn
Mar 31, 2023 13.07 Mn
Dec 31, 2022 11.45 Mn
Sep 30, 2022 16.06 Mn
Jul 1, 2022 20.84 Mn
Apr 1, 2022 11.37 Mn
Dec 31, 2021 20.00 Mn
Oct 1, 2021 22.09 Mn
Jul 2, 2021 29.43 Mn
Apr 2, 2021 21.52 Mn
Dec 31, 2019 -198,000.00
Jun 28, 2019 4.75 Mn
Mar 29, 2019 386,000.00